9th Medical Science Liaison Best Practices

2,023 views
1,862 views

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,023
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
43
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

9th Medical Science Liaison Best Practices

  1. 1. Bringing Maximum Value to the KOL, Company and Industry 9th MSL Best Practices September 26-27, 2011 | Hilton San Diego Resort & Spa | San Diego, CA Co-Located with ExL’s { 14th Investigator-Initiated Trials Conference For maximum learning and networking opportunities!Distinguished Speaking Featured Sessions Include:Faculty Joins us From:ALLERGAN REACTIVE VS. PROACTIVEAMGEN How Can MSLs Manage Thought Leader Interactions in a Regulatory Environment that Favors a Reactive Model?AuXILIuM Krystene Woodard, Associate Director, ADHD MSL Team, SHIRECAMPBELL ALLIANCECELGENE CORPORATION MSL AND MEDICAL AFFAIRS COLLABORATIONFOLEY & LARDNER Building and Maintaining Communication with Field-Based and Office-BasedGENZYME Teams to Strengthen Medical StrategyMEDTRONIC Mohamed Yassine, Director and Therapeutic Lead, RMLs, AMGENMILLENNIuMPFIZER PRE-CONFERENCE WORKSHOP: BUILDING AN MSL GROUP Elizabeth Faust, PhD, Susan Coughlin, PhD,SHIRE VP, Medical Affairs and Head of Oncology Regional Senior Director and National Lead,TAKEDA Medical Liaisons, CELGENE CORPORATION Solid-Tumor RMLs, CELGENE CORPORATIONTRINET PHARMA Plus! Off-Label InformationInteractive Roundtable Dissemination MSL Training Programs MSL Team Prioritizing Cohesiveness MSL Activities Career Development Emerging KOLsDiscussions: Sponsored by:Register Now 866-207-6528 | www.exlpharma.com/9thmsl
  2. 2. Who Should Attend? Professionals from Pharmaceutical, Biotechnology and Medical Device companies with responsibilities in the following areas:Dear Colleague, Departments/Titles • Medical Science Liaisons (MSLS, MLs)Medical Science Liaisons (MSLs) are essential to the long term sustainability and • Medical Advisorssuccess of pharmaceutical, biotech and medical device companies. Through the pro- • Scientific Advisorsvision of sound scientific education, speaker development, insights on access/reim- • Medical Managersbursement, and research support, the importance of these knowledgeable and skilled • Medical Scientistsindividuals cannot be overestimated. As competition mounts, pipelines dry, and the • Medical Affairsregulatory environment becomes increasingly restrictive, MSLs must be armed with • Scientific Affairsthe tools and techniques for bringing maximum value to key opinion leaders, internalstakeholders, and corporate decision makers. Further, MSL managers and directors • Regional Medical Education Officersmust be able to compliantly measure the effectiveness of their teams both in the field • Medical Communicationsand in communicating across internal departments. • Clinical Trial Liaisons • Clinical ResearchExL Pharma’s 9th MSL Best Practices conference has a long history of offering targeted • Medical Educationand highly practical content, in an engaging and interactive format. This event is a leader • Clinical/Outcomes Liaisonsin the provision the latest information for enhancing the impact of MSLs, while offering • Clinical Investigatorsample networking opportunities. As the role of the MSL continues to evolve, this confer- • KOL Developmentence adapts to meet the increasing information needs of such a high level audience. We • Business Intelligenceare excited to bring the most cutting edge concepts and techniques to our latest and • Regulatory Affairsgreatest MSL program to date! • MarketingWe look forward to greeting you in September!Sincerely, This conference is also “Excellent seminar…will of interest to: attend in the future” • Software and Technology CompaniesMatt Millman • Staffing Agencies/RecruitersTeam Leader, ProductionExL Pharma – MSL, Millennium • Law Firms • Consultants Hilton San Diego Resort and Spa 1775 E. Mission Bay Drive, San Diego, CA 92109 The Hilton San Diego Resort & Spa is just six miles from the San Diego International Airport, and right on San Diego’s famous Mission Bay. This resort and spa is conveniently located one mile from San Diego SeaWorld and offers 5-star service. A romantic paradise of palms and perfect sandy bayfronts, this bayside retreat is complete with our all-new $5 million dollar crown jewel, Spa Brezza, state-of-the-art fitness center, beautifully refreshed guestrooms, plus Concerts on the Bay. ROOM RESERVATIONS: If you require overnight accommodations, please contact the hotel and state that you are with ExL Pharma’s MSL conference by Monday, September 5, 2011. We encourage conference participants to make reservations with our designated venue to take advantage of ExL Pharma’s discounted room rate. To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl
  3. 3. PRE-CONFERENCE WORKSHOPDAY ONE – Monday, September 26th “I was really impressed with virtu- ally everything about this event. The topics were right on target, the speak-8:00 Registration and Continental Breakfast for Workshop Participants ers were great, having lots of time for9:00 PRE-CONFERENCE WORKSHOP ESTABLISHING A NEW MSL TEAM questions and interactive discussions Defining and Developing a Successful MSL Team was perfect.” • Gaining cross-functional alignment on roles and responsibilities – Medical Scientific Manager, Allergan • Determining size and structure • Hiring, training, and deploying a new team • Setting up a career ladder Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, CELGENE CORPORATION “Exceeded my expectations” Susan Coughlin, PhD, Senior Director and National Lead, Solid-Tumor RMLs, - MSL, Tercica CELGENE CORPORATION12:00 Lunch For Workshop AttendeesMAIN CONFERENCE BEGINS – DAY ONE1:00 CHAIRPERSON’S WELCOME AND OPENING REMARKS 3:15 ADDING VALUE TO THE MSL ROLE Elizabeth Faust, PhD, VP, Medical Affairs and Head of Oncology Utilizing MSL Skill Sets and Expertise to Support Other Regional Medical Liaisons, CELGENE CORPORATION Groups Within the Organization • What is the traditional view of the MSL role1:15 MSL AND MEDICAL AFFAIRS COLLABORATION Building and Maintaining Communication with Field-Based • What are ways to add value to, and increase visibility of, the and Office-Based Teams to Strengthen Medical Strategy work MSLs already do • Bringing thought leader insights to internal partners for coor- • What are other activities MSLs can do to bring value to dinated KOL engagement departments within the organization • Setting medical objectives that are aligned to corporate goals, • How are these activities prioritized and communicated internally mission and vision • What are the benefits and obstacles to increasing collabora- • Utilizing information from medical teams to support MSL tion with internal departments operations Eric Churchill, PhD, MSL, MILLENNIUM PHARMACEUTICALS • Establishing formal internal communication processes to 4:00 BEYOND METRICS promote clear, consistent and timely exchange of information Demonstrating Value Using Measures that Capture the Mohamed Yassine, Director and Therapeutic Lead, RMLs, Importance of MSLs to Corporate Business Objectives AMGEN • Determining the value MSLs bring to internal and external2:00 REACTIVE VS. PROACTIVE customers How Can MSLs Manage Thought Leader Interactions in a • Going beyond reach and frequency to compliantly assess Regulatory Environment that Favors a Reactive Model? MSL performance • Are more teams solely contacting physicians in response to • Selecting quantitative and qualitative metrics that are fair and questions instead of setting up appointments? Is this more meaningful to both MSLs and their leadership prevalent among new MSL teams? Stephen Liu, PharmD, Regional Associate Director, • What tactics are MSLs using to maintain relationships and TAKEDA PHARMACEUTICALS initiate contact with KOLs? • Where is the industry headed and what can be done to change the perception that MSLs are an extension of sales? “Very well run and designed” Krystene Woodard, Associate Director, ADHD MSL Team, SHIRE – National Clinical Science Manager, Abbott2:45 Networking and Refreshment Break To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl
  4. 4. MAIN CONFERENCE CONTINuESDAY ONE – Monday, September 26th4:45 COCKTAIL RECEPTION & ROUNDTABLE SESSIONS WITH ATTENDEES FROM 14TH INVESTIGATOR-INITIATED TRIALS CONFERENCE 1 2 3 Off-Label Information Dissemination: MSL Training Programs: What compo- MSL Team Cohesiveness: How can How can MSLs ensure compliant off- nents should be included in MSL training managers best promote a positive, label information sharing in the field? initiatives to enhance MSL knowledge motivated group? and develop interpersonal skills? 4 Prioritizing MSL Activities: What is the ideal allocation of MSL time and resources? 5 Career Development: Given the MSL skill set, what professional opportunities are complimentary within medical affairs, 6 Emerging KOLs: What are best practices for building relationships with “rising stars?” pharma, and other industries?6:00 Close Of Day One/Close Of Cocktail ReceptionMAIN CONFERENCE DAY TWO – Tuesday, September 27th8:00 Continental Breakfast for Conference Participants Panelists:9:00 CHAIRPERSON’S RECAP OF DAY ONE AND MODERATORS’ Stacey Benefiel, Senior MSL Manager, Coronary and Peripheral, KEY POINTS FROM ROUNDTABLE DISCUSSIONS MEDTRONIC Elizabeth Faust, PhD, David Cram, PharmD, Vice President, Medical Affairs RSS Team, VP, Medical Affairs and Head of Oncology Regional Medical Liaisons, ALLERGAN CELGENE CORPORATION Doug Wolf, Senior Director Team Leader Oncology RMRS, PFIZER9:15 LIFECYCLE MANAGEMENT 10:45 Networking and Refreshment Break Allocating Time and Resources to Different Functions 11:15 KOL DEVELOPMENT based on the Product’s Stage in its Lifecycle Optimizing Thought Leader Engagement for Lasting • Pre-Launch Phase: Successful strategies for KOL identification, Relationships throughout the Product Lifecycle enhancing disease state awareness and providing clinical support • Enhancing internal communication across departments for a • Launch Phase: Compliantly and effectively lending support to coordinated outreach strategy advisory boards, speaker training, managed care and possibly • Discussing best practices for identifying and working with “ris- sales training ing stars” • Post-Launch Phase: Facilitating risk management, Investigator- • Identifying compliance considerations when communicating Initiated studies, and Phase IV studies through sustained scien- with thought leaders tific exchange with thought leaders CAMPBELL ALLIANCE Cindy Sellers O’Brien, RN, BSN, MBA, Director, Medical Science Liaison Team - Solid Organ Transplant, 12:00 INTERNAL STAKEHOLDER COLLABORATION GENZYME TRANSPLANT AND ONCOLOGY Compliantly Communicating with Commercial Teams10:00 PANEL DISCUSSION: FUTURE TRENDS • Maintaining compliance while sharing information with sales, Looking at the Medical Science Liaison Position in 2015 marketing, managed care, and other internal partners • How will the position evolve? • Establishing and maintaining the firewall between commercial • How will regulations change? and medical teams • Will the numbers go up or down • Handling off-label information requests and information dis- semination Moderator: Michael R. Ujhelyi, PharmD, FCCP, Director, Medical Affairs Bryan Vaughan, Managing Member, TRINET PHARMA and Safety, MEDTRONIC To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl
  5. 5. MAIN CONFERENCE CONTINuESDAY TWO – Tuesday, September 27th 12:45 Luncheon for Conference Participants 2:30 LEGAL AND COMPLIANCE OVERVIEW Outlining Selected State, Federal and Industry Guidelines 1:45 REMS: WHY IT IS IMPORTANT TO THE MSL ROLE for Compliant Scientific Information Exchange • Exploring the evolution and prevalence of REMS across the • Discussing the “Sunshine Act” provisions and their impact on industry MSL activities • Discussing how MSLs can best support a REMS in collabora- • Reviewing state-mandated restrictions on industry-KOL inter- tion with cross-functional departments actions and the likelihood of other states following suit • Considering future trends and associated roles and responsi- • Highlighting industry and stakeholder initiated transparency bilities of MSLs in minimizing risk and supporting drug safety • Developing and enforcing SOPs to minimize risk and protect Gail Rosen Spahn, PharmD, Senior Director, Medical Affairs, your company AUXILIUM PHARMACEUTICALS Judith Waltz, Partner, FOLEY & LARDNER LLP 3:30 Chairperson’s Closing Remarks/Conference ConcludesSponsorship and Exhibiting OpportunitiesDo you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event? Takeadvantage of the opportunity to exhibit, present an educational session, host a networking event, or distribute promotional items to attendees. ExLPharma will work closely with you to customize a package that will suit all of your needs. To learn more about these opportunities, please contact:Steve Decker, Business Development Manager 212-400-6234 | sdecker@exlpharma.com MediaPartners Five Ways to Register Group Discount Program: Cancellations: Mail: ExL Events, Inc. Save 25% per person when Registering Four If you need to cancel your registration for an upcoming 555 8th Ave, Ste 310 For every three simultaneous registrations from ExL conference, please note the following policies derived New York, NY 10018 your company, you will receive a fourth com- from the Start Date of the event: Phone: 212-400-6233 plimentary registration to the program (must Four weeks or more: A full refund (minus a $95 register 4 at one time). This is a savings of 25% processing fee), or a voucher to another ExL event valid Fax: 888-221-6750 per person. for two years from the voucher issue date. Email: register@exlpharma.com Save 15% per person when Registering Three Four weeks or Less: A voucher to another ExL event Online: www.exlpharma.com/9thmsl valid for two years from the voucher issue date. Can only send three? You can still save 15% off of every registration. To find out more on To receive a refund or voucher, please fax your request EARLY BIRD PRICING how you can take advantage of these group to 888-221-6750. Register by Friday, August 12, 2011 to discounts, please call 866-207-6528. Please Note: Conference registrations may be trans- Take Advantage of Early-Bird Pricing: Important! Discounts may not be combined. ferred to other colleagues in the event you are unable to Discount applies only to standard rate. Make attend. There will be an administrative charge of $300 to Conference + Workshop $1995 checks payable to ExL Events, Inc. and write substitute, exchange and/or replace attendance badges Conference Only $1695 code P1130 on your check. with a colleague occurring within five business days of You may also use Visa, MasterCard, Discover or any ExL conference. STANDARD PRICING American Express. Payments must be received Please notify ExL Pharma, info@exlpharma.com, prior to in full prior to the commencement of the the event with the name and contact information of the Register After Friday, August 12, 2011: conference. replacement attendee. Conference + Workshop $2195 Conference Only $1895 *In the event of a cancellation or postponement ExL Events, Inc. will not be liable and/or responsible for any individual or group expenses related to said conference ONSITE PRICING Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancella- Conference + Workshop $2295 tion, every effort to find a suitable replacement will be made. Conference Only $1995 *The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc.* To Register Call 866-207-6528 or visit www.exlpharma.com/9thmsl
  6. 6. To Register: METHOD OF PAYMENT: q Check q Credit Card Make checks payable to ExL Events, Inc. ExL Events, Inc. 866-207-6528 CARD TYPE: q MasterCard q Visa q Discover q Amex 555 8th Avenue, Suite 310 New York, NY 10018 888-221-6750 Card Number: Exp. Date: www.exlpharma.com/9thmsl Name on Card:q Yes! Register me for the Conference Only Signature:q Yes! Register Me for the Conference and WorkshopPlease contact me: 555 8th Avenue, Suite 310q I’m interested in marketing opportunities at this event New York, NY 10018q I wish to receive email updates on Exl Pharma’s upcoming events PLEASE MENTION PRIORITY CODE: P1130Name:Title:Company:Dept.:Address:City: State: Zip:Email:Telephone: Fax: Bringing Maximum Value to the KOL, Company and Industry 9th MSL Best Practices September 26-27, 2011 | Hilton San Diego Resort & Spa | San Diego, CA Co-Located with ExL’s { 14th Investigator-Initiated Trials Conference For maximum learning and networking opportunities!Sponsored by:Register Now 866-207-6528 | www.exlpharma.com/9thmsl

×